Αποτελέσματα Αναζήτησης
27 Ιουλ 2023 · There is an even greater paucity of data to guide management of COPD and asthma in people living with HIV. Instead, the findings of studies in people without HIV have been extrapolated to...
- Metrics
We would like to show you a description here but the site...
- Full Size Image
We would like to show you a description here but the site...
- Metrics
12 Μαΐ 2014 · Asthma and COPD are more prevalent in HIV-infected populations; 16–20% of individuals with HIV infection have asthma or COPD, and poorly controlled HIV infection worsens spirometric and diffusing capacity measurements, and accelerates lung function decline by about 55–75 mL/year.
As the recent outpatient data are leaning more in favour of positive association between HIV and asthma prevalence, data regarding the role of HIV in acute asthma exacerbation are not as robust as COPD.11 Therefore, we aimed to evaluate and compare the outcomes of HIV-positive and HIV-negative patients with asthma who were admitted to the ...
28 Ιαν 2018 · Abstract. HIV in the antiretroviral therapy era is characterized by multimorbidity and the frequent occurrence of HIV -associated non-AIDS chronic health conditions.
23 Δεκ 2019 · We aimed to compare the outcomes of HIV-positive and HIV-negative patients following hospital admission for asthma exacerbation. Methods: A retrospective chart review of patients hospitalised between January 2015 and December 2017 owing to asthma exacerbation with a known HIV status was conducted.
1 Απρ 2012 · Research evaluating the cellular and physiological changes occurring after HIV infection and initiation of antiretroviral therapy is needed to advance our understanding of HIV-associated respiratory symptoms and its potential link to obstructive airway diseases such as asthma and COPD.
20 Ιουλ 2023 · The main purpose of this study was to assess medication adherence and persistence with inhaled medications for chronic treatment of asthma and COPD, as well as to evaluate the factors influencing this adherence.
